Basic Information
Basic information for MIR646HG-270-31aa
Peptide Name MIR646HG-270-31aa
Genome Position chr20:60096910-60097002[+]
Species Human
Peptide Sequence MLSPARKPSAVSVQDGSPRRNLSEVLCDLHN
Peptide Length 31
Unique No (MIR646HG-232-31aa,MIR646HG-233-31aa,MIR646HG-244-31aa,MIR646HG-249-31aa)
Grand Average of Hydropathicity -0.4839
Relative Molecular Mass 3918.26
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000671305;MIR646HG-270
Transcript Length 1564
Coding Ability 0.2583
DNA Sequence Corresponding to Peptide ATGCTGTCACCTGCCAGAAAGCCCTCGGCAGTCAGTGTCCAAGATGGCTCCCCACGCAGGAATCTCTCTGAAGTGCTCTGTGATCTCCACAAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :